biphasic human insulin
biphasic human insulin is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
Clinical Trials (7)
Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7